Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Creation of a Weakly Virulent Strep A Mutant May Boost Vaccine Development

By BiotechDaily International staff writers
Posted on 23 Jun 2014
Image: Electron micrograph, false color, of group A Streptococcus bacteria (Photo courtesy of the University of California, San Diego).
Image: Electron micrograph, false color, of group A Streptococcus bacteria (Photo courtesy of the University of California, San Diego).
Creation of a mutated variety of Group A Streptococcus (GAS) bacteria with reduced virulence but complete immunological expression may pave the way for development of a safe vaccine to prevent infections such as strep throat, necrotizing fasciitis, and rheumatic heart disease, which are caused by these organisms.

All GAS serotypes express the Lancefield group A carbohydrate (GAC), comprising a polyrhamnose backbone with an immunodominant N-acetylglucosamine (GlcNAc) side chain, which is the basis of rapid diagnostic tests. No biological function has so far been attributed to this conserved antigen.

Investigators at the University of California, San Diego (USA) recently identified the genetic locus for GAC and used this knowledge to create a strep A mutant that lacked the GlcNAc side-chain addition. They reported in the June 11, 2014, issue of the journal Cell Host & Microbe that this mutant was significantly less virulent than the wild type organism in two infection models, in association with increased sensitivity to neutrophil killing, platelet-derived antimicrobials in serum, and the antimicrobial peptide LL-37.

The investigators also showed that antibodies to GAC lacking the GlcNAc side chain and containing only polyrhamnose promoted killing of multiple GAS serotypes and protected against systemic GAS challenge after passive immunization.

These findings demonstrated that the Lancefield antigen played a functional role in GAS pathogenesis, and that a deeper understanding of this unique polysaccharide has implications for vaccine development.

“It is satisfying to find that a fundamental observation regarding the genetics and biochemistry of the pathogen can have implications not only for strep disease pathogenesis, but also for vaccine design,” said senior author Dr. Victor Nizet, professor of pediatrics and pharmacy at the University of California, San Diego.

“Most people experience one or more painful strep throat infections as a child or young adult. Developing a broadly effective and safe strep vaccine could prevent this suffering and reduce lost time and productivity at school and work, estimated to cost two billion USD annually.”

Related Links:
University of California, San Diego



RANDOX LABORATORIES
BIOSIGMA S.R.L.
SLAS - Society for Laboratory Automation and Screening
comments powered by Disqus

Channels

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel

e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit

A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage. Offering the potential to test... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.